HIV/AIDS Treatment for Millions
HIV/AIDS Treatment for Millions
复制标题
为数百万人提供艾滋病毒/艾滋病治疗
作者：
H. P. Binswanger
制药公司终于宣布大幅降低非洲抗逆转录病毒药物的价格。一般制造商提供的价格甚至更低。如果仿制药生产商和专利持有者之间的竞争能够保持或加强，抗逆转录病毒药物的价格有可能进一步下降。数百万人现在买得起这些药物。还有数百万人没有保险，无力支付。贫穷国家的政府也无力为这些药物提供补贴。因此，大型捐赠项目必须由发达国家的公共和私人捐赠提供资金。迅速扩大抗逆转录病毒治疗需要艾滋病毒/艾滋病患者协会、医疗协会、私人和公共捐助者迅速采取补充行动，并促进穷国政府和国际组织采取行动。
Pharmaceutical companies have at last announced sharp price reductions for antiretroviral (ARV) medication in Africa. Prices offered by generic manufacturers are even lower. If competition among generic drug producers and patent holders can be maintained or intensified, further drops in ARV prices are likely. Millions can now afford the drugs. Many more millions are uninsured and cannot afford to pay. Nor can governments of poor countries afford to subsidize the drugs. Large donation programs must therefore be financed by public and private donations from developed countries. Fast expansion of ARV treatment requires quick complementary actions by associations of people living with HIV/AIDS, medical associations, and private and public donors, and facilitating actions by poor governments, and international organizations.